Centrum silver and Arixtra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 39 people who take Centrum silver and Arixtra. Common interactions include pyrexia among females, and plasma cell myeloma among males.

The phase IV clinical study analyzes what interactions people who take Centrum silver and Arixtra have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2023

39 people who take Centrum silver and Arixtra together, and have interactions are studied.


What is Centrum silver?

Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is used in vitamin supplementation. Currently, eHealthMe is studying from 19,701 Centrum silver users.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is used in deep venous thrombosis. Currently, eHealthMe is studying from 9,694 Arixtra users.

Number of Centrum silver and Arixtra reports submitted per year:

Centrum silver and Arixtra drug interactions.

Common Centrum Silver and Arixtra drug interactions by gender *:

female:

  1. Pyrexia
  2. Anxiety
  3. Arthralgia
  4. Cardiac failure congestive
  5. Chondromalacia
  6. Deformity
  7. Dizziness
  8. Dry mouth
  9. Emotional distress
  10. Epistaxis

male:

  1. Plasma cell myeloma
  2. Pruritus
  3. Axonal neuropathy
  4. Back pain
  5. Barrett's oesophagus
  6. Bone disorder
  7. Bone lesion
  8. Bone pain
  9. Bone swelling
  10. Bronchial secretion retention


Common Centrum Silver and Arixtra drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Adverse drug reaction

50-59:

  1. Osteoarthritis
  2. Pain
  3. Pain in extremity
  4. Pain in jaw
  5. Pyrexia
  6. Cardiac failure congestive
  7. Deformity
  8. Dry mouth
  9. Emotional distress
  10. Eye infection

60+:

  1. Chest pain
  2. Epistaxis
  3. Alopecia
  4. Altered state of consciousness
  5. Anogenital warts
  6. Anxiety
  7. Arrhythmia
  8. Arthralgia
  9. Bone disorder
  10. Bone pain

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 20.51%
  2. Breast Cancer: 3 people, 7.69%
  3. Pain: 2 people, 5.13%
  4. Osteoporosis (bones weak and more likely to break): 2 people, 5.13%
  5. Nausea And Vomiting: 2 people, 5.13%
  6. Nausea (feeling of having an urge to vomit): 2 people, 5.13%
  7. Metastases To Bone (cancer spreads to bone): 2 people, 5.13%
  8. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Centrum silver and Arixtra?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Centrum silver drug interactions:

Browse interactions between Centrum silver and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Arixtra drug interactions:

Browse interactions between Arixtra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e and fondaparinux sodium (the active ingredients of Centrum silver and Arixtra, respectively), and Centrum silver and Arixtra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Centrum silver and Arixtra.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: